Novartis Raises FullYear Sales and Profit Guidance on Strong Operational Performance Why Bonds May Not Provide the Expected Safety Net in the Next Market Shock Cigna Group CI Downgraded to Hold by Deutsche Bank Amid Portfolio Restructuring Concerns Meta Plans 6065 Billion AI Infrastructure Investment in 2025 Cancer Treatment Costs Soar ACA Could Have Eased Burden Survivor Suggests AI Industry Emerges as Key Beneficiary in MuskAltman Trial Revealing Sector Dynamics RILYP Q1 2024 Earnings Preferred Stock Reports Loss Amid Challenging Quarter GRRR Q4 2025 Earnings Significant EPS Miss Amidst Unclear Revenue Outlook TWFG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency BCDA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline Clipper Realty Inc Q1 2026 Earnings Positive EPS of 005 Highlights Resilient Operations CME Q1 2026 Earnings EPS Slightly Misses Consensus as Shares Edge Higher Park National Corporation Holds Steady as Support Levels Provide a Foundation OKYO Pharma Shows Cautious Uptick Amid Biotech Sector Movements M3Brigade Acquisition VI Corp Warrant MBVIW Holds Steady at 040 Near Key Support First Capital Inc FCAP Edges Higher Resilience Near Key Resistance Levels Hudbay Minerals HBM Faces Resistance Price Action Holds Above Key Support AMD CEO Projects Unprecedented CPU Demand Surge Spanning Five Years Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amid Quiet Trading Session Kiniksa Pharmaceuticals KNSA Slips 193 as Stock Tests 52 Level